Event Details
7th TCR-Based Therapies Summit
The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not guaranteed at approval. Addressing manufacturing costs, durability and long-term commercial viability is now mission critical for developers of TCR-based cell and biologic therapies.
Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the 7th TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Connect with and hear directly from senior leaders driving progress at the forefront of the field, including C-suite leaders at Immunocore, Immatics, T-knife Therapeutics, Anocca, Zelluna Immunotherapy, Enara Bio, Marengo Therapeutics, and 3T Biosciences.
With the foundations now in place, join us in empowering the community to shape a more durable, scalable, and commercially robust future for TCR-based therapies.
Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the 7th TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Connect with and hear directly from senior leaders driving progress at the forefront of the field, including C-suite leaders at Immunocore, Immatics, T-knife Therapeutics, Anocca, Zelluna Immunotherapy, Enara Bio, Marengo Therapeutics, and 3T Biosciences.
With the foundations now in place, join us in empowering the community to shape a more durable, scalable, and commercially robust future for TCR-based therapies.
Entry Fees
Free Registration
Categories
Event Frequency
One Time
Event Timings
(GMT-4:00) Eastern Time (US and Canada)
08:30 AM - 05:00 PM (May 18, May 19, May 20) (General)
Speakers
Tao Wang
Associate Professor, Bioinformatics and Computational Biology, The University of Texas MD Anderson C
Cassian Yee
Director, T-Cell-Based Therapies (ProTCT), Division of Cancer Medicine, The University of Texas MD A
Sarah Leonard
Vice President, Preclinical Development, TCR-Based Therapeutics, T-Cypher Bio
Mollie Jurewicz
Director, TCR and Autoimmune Discovery, TScan Therapeutics
Organizer
Hanson Wade
4 Followers
Follow
Hanson Wade specialises in bringing people together through outstanding business conferences and year round community contact.
Tags
Comments on 7th TCR-Based Therapies Summit
You must Login to write a comment.
Peoples Interested in Visit
0 Peoples Interested to Visit
Event Location
The Colonnade Hotel
120, Huntington Avenue ,
Boston 02116, Massachusetts, United States
Boston 02116, Massachusetts, United States
Official Link :
Featured Event
Please Wait...
More Events By Organizer
23
Jun
2026
LEAP HR: Higher Education 2026
Nashville, United States
Free
Conferences
23
Jun
2026
6th Fermentation-Enabled Alternative Protein Summit
San Francisco, United States
Free
Conferences
23
Jun
2026
8th T-Cell Engager Therapeutics Summit
San Diego County, United States
Free
Conferences
20
Jul
2026
6th mRNA-Based Therapeutics Summit
Boston, United States
Free
Conferences
07
Jul
2026
World Bispecific Summit Europe
Greater London, United Kingdom
Free
Conferences
14
Jul
2026
4th Obesity and Weight Loss Drug Development 2026
Boston, United States
Free
Conferences
Similar Events
21
Feb
2024
6th CAR-TCR Summit Europe: Driving Next Generation CAR an...
Greater London, United Kingdom
Free
Conferences
23
Apr
2024
5th TCR-based Therapies for Solid Tumors Summit 2024
Boston, United States
Free
Conferences
01
Apr
2025
6th TCR-Based Therapies Summit
Boston, United States
Free
Conferences
22
Jul
2025
13th Tumor Models Summit Boston | July 22-23, 2025 | Bost...
Boston, United States
Free
Conferences
23
Jun
2026
8th T-Cell Engager Therapeutics Summit
San Diego County, United States
Free
Conferences